Jobs / United States / Pfizer INC
Sr Director, Clinical Excellence Group Lead (I&I)
Pfizer INC · 🇺🇸 United States - Massachusetts - Cambridge
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles1 certified filing for “CLINICAL STATISTICIAN, ASSOCIATE DIRECTOR” (Data Scientists) in MA: $183k–$183k, median $183k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
The Inflammation & Immunology Clinical Excellence & Innovation organization is seeking an experienced and enterprise-minded clinical development leader to serve as Senior Director, Clinical Excellence Group Lead. This highly visible role provides strategic clinical, scientific, operational, and people leadership across a portfolio of complex clinical development programs. The successful candidate will lead and develop a team of clinical scientists while ensuring oversight of clinical integrity, scientific quality, patient safety, and disciplined execution across studies within the Dermatology Franchise. This leader will also help advance new ways of working, including the responsible integration of AI-enabled, digital, data, and advanced analytics capabilities to improve clinical development quality, speed, and decision-making. As a senior change leader within a highly experienced matrix organization, this individual will bring strategic clarity, operational discipline, and collaborative influence to address portfolio challenges, optimize resource allocation, and scale effective solutions across the clinical trial lifecycle. KEY RESPONSIBILITIES Team Leadership & Change Management • Lead, mentor, and develop a team of high-performing clinical scientists, fostering a culture of collaboration, accountability, continuous learning, intellectual curiosity, and agility. • Act as a change champion, guiding a highly tenured organization through digital transformation and new ways of working. • Drive change management initiatives that encourage the adoption of innovative tools and process optimizations without compromising scientific rigor. • Build strong, collaborative partnerships with Clinical Operations, Data Science, Biostatistics, Digital/Technology, Regulatory, Medical Affairs, Portfolio Strategy, and Business Operations to align clinical science objectives with broader enterprise goals. • Portfolio planning, lifecycle management, and evaluation of future growth opportunities. Business Operations & Enterprise Strategy · Apply strong business acumen to identify operational bottlenecks within clinical development and lead cross-functional workstreams to design and implement scalable solutions. • Partner with cross-functional teams on enterprise initiatives to develop and implement fit-for-purpose operating practices, tools, and governance approaches that enable a well-controlled, flexible organization with strong fiscal management, cross-team communication, and efficient workflows. • Establish and leverage standardized frameworks to evaluate clinical program designs, resource needs, and workflows through an operational efficiency lens, ensuring resources are optimized and key milestones are supported. • Support generating business insights, metrics, and dashboards to inform decision-making, monitor therapeutic area performance, and identify opportunities to improve quality, speed, productivity, and portfolio impact. • Navigate a complex matrix environment with an enterprise mindset, ensuring that innovation strategies in I&I can scale and align with broader Pfizer corporate objectives. AI-Enabled Clinical Development & Innovation · Partner closely with data science, digital, and technology teams to translate complex AI use cases into practical, scalable, compliant workflows for study teams. · Lead the identification, strategic development, and implementation of AI/ML and advanced analytics tools to optimize clinical trial design and execution. · Direct applied AI/ML approaches across the continuum, including: · Protocol design and optimization · Site selection and feasibility assessment · Patient recruitment and enrollment strategies · Query management and workflow automati